UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2002-11, Vol.20 (21), p.4285-4291

2002

Volltextzugriff (PDF)

Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials

Annals of oncology, 2022-02, Vol.33 (2), p.119-122

2022

Volltextzugriff (PDF)

Testing for COVID-19 in lung cancer patients

Annals of oncology, 2020-07, Vol.31 (7), p.832-834

2020

Volltextzugriff (PDF)

CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials

Annals of oncology, 2018-03, Vol.29 (3), p.687-693

2018

Volltextzugriff (PDF)

Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series

Neoplasma, 2020-01, Vol.67 (3), p.684-691

2020

Volltextzugriff (PDF)

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Annals of oncology, 2022-05, Vol.33 (5), p.466-487

2022

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3522-3530

1999

Volltextzugriff (PDF)

A simple smartphone-aided program to support meaningful occupation in people with severe neuro-motor and speech disabilities

International journal of rehabilitation research, 2023-06, Vol.46 (2), p.205-208

2023

Volltextzugriff (PDF)

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted Therapy

Current medicinal chemistry, 2012-11, Vol.19 (32), p.5524-5535

2012

Volltextzugriff (PDF)

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT)

ESMO open, 2023-04, Vol.8 (2), p.101192-101192, Article 101192

2023

Volltextzugriff (PDF)

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

Clinical & translational oncology, 2020-04, Vol.22 (4), p.603-611

2020

Volltextzugriff (PDF)

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

Lung cancer (Amsterdam, Netherlands), 2011-03, Vol.71 (3), p.249-257

2011

Volltextzugriff (PDF)

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology

ESMO open, 2022-02, Vol.7 (1), p.100355, Article 100355

2022

Volltextzugriff (PDF)

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.149-158

2020

Volltextzugriff (PDF)

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

Radiotherapy and oncology, 2020-08, Vol.149, p.84-88

2020

Volltextzugriff (PDF)

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.6-11

2020

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer

Annals of oncology, 2005-05, Vol.16 (suppl-4), p.iv116-iv122

2005

Volltextzugriff (PDF)

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Journal of clinical oncology, 2005-05, Vol.23 (13), p.3125-3137

2005

Volltextzugriff (PDF)

Treatment of advanced non-small cell lung cancer

Annals of oncology, 2006-01, Vol.17 (suppl-2), p.ii36-ii41

2006

Volltextzugriff (PDF)

Quality of life in lung cancer patients

Annals of oncology, 2001, Vol.12 (suppl-3), p.S21-S25

2001

Volltextzugriff (PDF)

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

Clinical lung cancer, 2023-01, Vol.24 (1), p.e19-e26

2023

Volltextzugriff (PDF)

Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs

Annals of oncology, 2019-04, Vol.30, p.ii54-ii54

2019

Volltextzugriff (PDF)

Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC

Annals of oncology, 2019-04, Vol.30, p.ii57-ii57

2019

Volltextzugriff (PDF)

IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC

Annals of oncology, 2019-10, Vol.30, p.v915

2019

Volltextzugriff (PDF)

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Annals of oncology, 2011-07, Vol.22 (7), p.1528-1534

2011

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(472)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(206)
Science & Technology
(197)
Life Sciences & Biomedicine
(187)
Female
(131)
Male
(121)
Middle Aged
(113)
Adult
(104)
Aged
(99)
Oncology
(93)
Biological And Medical Sciences
(92)
Medical Sciences
(86)
Lung Neoplasms - Drug Therapy
(79)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(70)
Endocrinology & Metabolism
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(46)
Lung Neoplasms - Pathology
(38)
Treatment Outcome
(36)
Aged, 80 And Over
(33)
Chemotherapy
(33)
Carcinoma, Non-Small-Cell Lung - Pathology
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials

Testing for COVID-19 in lung cancer patients

CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials

Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

A simple smartphone-aided program to support meaningful occupation in people with severe neuro-motor and speech disabilities

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted Therapy

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT)

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology

Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer

Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

Treatment of advanced non-small cell lung cancer

Quality of life in lung cancer patients

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs

Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC

IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Suchergebnisse filtern